Impacts of Glycemic Control on Intracranial Plaque in Patients with Type 2 Diabetes Mellitus: A Vessel Wall MRI Study

References

1. 1.↵
   1. Christen AI,
   2. Armentano RL,
   3. Miranda A, et al

   . Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings. Curr Diabetes Rev 2010;6:367–77 doi:10.2174/157339910793499146 pmid:20879975

   CrossRefPubMed
2. 2.↵
   1. Moreno PR,
   2. Fuster V

   . New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004;44:2293–2300 doi:10.1016/j.jacc.2004.07.060 pmid:15607389

   FREE Full Text
3. 3.↵
   1. Creager MA,
   2. Lüscher TF,
   3. Cosentino F, et al

   . Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy, Part I. Circulation 2003;108:1527–32 doi:10.1161/01.CIR.0000091257.27563.32 pmid:14504252

   FREE Full Text
4. 4.↵
   1. Beckman JA,
   2. Creager MA,
   3. Libby P

   . Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570–81 doi:10.1001/jama.287.19.2570 pmid:12020339

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Selvin E,
   2. Coresh J,
   3. Golden SH

   , et al; Atherosclerosis Risk in Communities Study. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 2005;28:1965–73 doi:10.2337/diacare.28.8.1965 pmid:16043740

   Abstract/FREE Full Text
6. 6.↵
   1. Yang DJ,
   2. Lee MS,
   3. Kim WH, et al

   . The impact of glucose control on coronary plaque composition in patients with diabetes mellitus. J Invasive Cardiol 2013;25:137–41 pmid:23468443

   PubMed
7. 7.↵
   1. Tavares CA,
   2. Rassi CH,
   3. Fahel MG, et al

   . Relationship between glycemic control and coronary artery disease severity, prevalence and plaque characteristics by computed tomography coronary angiography in asymptomatic type 2 diabetic patients. Int J Cardiovasc Imaging 2016;32:1577–85 doi:10.1007/s10554-016-0942-9 pmid:27432440

   CrossRefPubMed
8. 8.↵
   1. Moossy J

   . Morphology, sites and epidemiology of cerebral atherosclerosis. Res Publ Assoc Res Nerv Ment Dis 1966;41:1–22 pmid:5334399

   PubMed
9. 9.↵
   1. Velican C

   . Studies on the age-related changes occurring in human cerebral arteries. Atherosclerosis 1970;11:509–29 doi:10.1016/0021-9150(70)90029-8 pmid:5433089

   CrossRefPubMed
10. 10.↵
    1. Ryu CW,
    2. Kwak HS,
    3. Jahng GH, et al

    . High-resolution MRI of intracranial atherosclerotic disease. Neurointervention 2014;9:9–20 doi:10.5469/neuroint.2014.9.1.9 pmid:24644529

    CrossRefPubMed
11. 11.↵
    American Diabetes Association. Standards of Medical Care in Diabetes-2019 Abridged for Primary Care Providers. Clin Diabetes 2019;37:11–34 doi:10.2337/cd18-0105 pmid:30705493

    FREE Full Text
12. 12.↵
    1. Chimowitz MI,
    2. Kokkinos J,
    3. Strong J, et al

    . The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488–93 doi:10.1212/wnl.45.8.1488 pmid:7644046

    Abstract/FREE Full Text
13. 13.↵
    1. Skarpathiotakis M,
    2. Mandell DM,
    3. Swartz RH, et al

    . Intracranial atherosclerotic plaque enhancement in patients with ischemic stroke. AJNR Am J Neuroradiol 2013;34:299–304 doi:10.3174/ajnr.A3209 pmid:22859280

    Abstract/FREE Full Text
14. 14.↵
    1. Li F,
    2. Chen QX,
    3. Chen ZB, et al

    . Magnetic resonance imaging of plaque burden in vascular walls of the middle cerebral artery correlates with cerebral infarction. CNR 2016;13:263–70 doi:10.2174/1567202613666160829095324 pmid:27573442

    CrossRefPubMed
15. 15.↵
    1. Ryu CW,
    2. Jahng GH,
    3. Kim EJ, et al

    . High-resolution wall and lumen MRI of the middle cerebral arteries at 3 Tesla. Cerebrovasc Dis 2009;27:433–42 doi:10.1159/000209238 pmid:19295206

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Huang J,
    2. Jiao S,
    3. Zhao X, et al

    . Characteristics of patients with enhancing ICAS and association between plaque enhancement and recent cerebrovascular ischemic events: a high-resolution magnetic resonance imaging study. Acta Radiol 2019;60:1301–07 doi:10.1177/0284185118822645 pmid:30650984

    CrossRefPubMed
17. 17.↵
    1. Brohall G,
    2. Odén A,
    3. Fagerberg B

    . Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006;23:609–16 doi:10.1111/j.1464-5491.2005.01725.x pmid:16759301

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Sun B,
    2. Zhao H,
    3. Liu X, et al

    . Elevated hemoglobin A1c is associated with carotid plaque vulnerability: novel findings from magnetic resonance imaging study in hypertensive stroke patients. Sci Rep 2016;6:33246 doi:10.1038/srep33246 pmid:27629481

    CrossRefPubMed
19. 19.↵
    1. Aronson D,
    2. Rayfield EJ

    . How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 2002;1:1 doi:10.1186/1475-2840-1-1 pmid:12119059

    CrossRefPubMed
20. 20.↵
    1. Katakami N

    . Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb 2018;25:27–39 doi:10.5551/jat.RV17014 pmid:28966336

    CrossRefPubMed
21. 21.↵
    1. O’Brien KD,
    2. Allen MD,
    3. McDonald TO, et al

    . Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993;92:945–51 doi:10.1172/JCI116670 pmid:7688768

    CrossRefPubMedWeb of Science
22. 22.↵
    1. O’Brien KD,
    2. McDonald TO,
    3. Chait A, et al

    . Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93:672–82 doi:10.1161/01.CIR.93.4.672 pmid:8640995

    Abstract/FREE Full Text
23. 23.↵
    1. Moulton KS,
    2. Vakili K,
    3. Zurakowski D, et al

    . Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 2003;100:4736–41 doi:10.1073/pnas.0730843100 pmid:12682294

    Abstract/FREE Full Text
24. 24.↵
    1. Celletti FL,
    2. Waugh JM,
    3. Amabile PG, et al

    . Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001;7:425–29 doi:10.1038/86490 pmid:11283668

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Lou X,
    2. Ma N,
    3. Ma L, et al

    . Contrast-enhanced 3T high-resolution MR imaging in symptomatic atherosclerotic basilar artery stenosis. AJNR Am J Neuroradiol 2013;34:513–17 doi:10.3174/ajnr.A3241 pmid:22878005

    Abstract/FREE Full Text
26. 26.↵
    1. Ryu CW,
    2. Jahng GH,
    3. Shin HS

    . Gadolinium enhancement of atherosclerotic plaque in the middle cerebral artery: relation to symptoms and degree of stenosis. AJNR Am J Neuroradiol 2014;35:2306–10 doi:10.3174/ajnr.A4038 pmid:25012673

    Abstract/FREE Full Text
27. 27.↵
    1. Qiao Y,
    2. Zeiler SR,
    3. Mirbagheri S, et al

    . Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images. Radiology 2014;271:534–42 doi:10.1148/radiol.13122812 pmid:24475850

    CrossRefPubMed
28. 28.↵
    1. Moreno PR,
    2. Murcia AM,
    3. Palacios IF, et al

    . Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000;102:2180–84 doi:10.1161/01.cir.102.18.2180 pmid:11056089

    Abstract/FREE Full Text
29. 29.↵
    1. Gao X,
    2. Song J,
    3. Watase H, et al

    ; CARE-II Investigators. Differences in carotid plaques between symptomatic patients with and without diabetes mellitus. Arterioscler Thromb Vasc Biol 2019;39:1234–39 doi:10.1161/ATVBAHA.118.312092 pmid:31070472

    CrossRefPubMed
30. 30.↵
    1. Meigs JB,
    2. Nathan DM,
    3. Cupples LA, et al

    . Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol 1996;49:411–17 doi:10.1016/0895-4356(95)00513-7 pmid:8621991

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Mukai N,
    2. Ninomiya T,
    3. Hata J, et al

    . Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study. Cardiovasc Diabetol 2015;14:24 doi:10.1186/s12933-015-0247-7 pmid:26099223

    CrossRefPubMed
32. 32.↵
    1. Choi N,
    2. Lee JY,
    3. Sunwoo JS, et al

    . Recently uncontrolled glycemia in diabetic patients is associated with the severity of intracranial atherosclerosis. J Stroke Cerebrovasc Dis 2017;26:2615–21 doi:10.1016/j.jstrokecerebrovasdis.2017.06.025 pmid:28784278

    CrossRefPubMed